Off-Label Use of Rituximab in Refractory Pediatric Rheumatic Diseases: A Single-Center Experience

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-12-s1-p343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Off-Label Use of Rituximab in Dermatology: Pemphigus Treatment

Anais Brasileiros de Dermatologia
Dermatology
2013English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Available Evidence and Outcome of Off-Label Use of Rituximab in Clinical Practice

European Journal of Clinical Pharmacology
MedicinePharmacology
2013English

Subcutaneous Rituximab in B-Cell Non-Hodgkin Lymphoma: A Single-Center Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

AB0506 Pregnancy Outcomes in Women With Rheumatic Diseases: A Single Center-Study

2017English

1594 Laproscopic Cholecystectomy in the Pediatric Population: A Single Center Experience

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2012English

Transpapillary Drainage of Walled-Off Pancreatic Necrosis – A Single Center Experience

Wideochirurgia I Inne Techniki Maloinwazyjne
GynecologySurgeryUrologyObstetricsGastroenterology
2015English

Systemic Lupus Erythematosus: Extent and Patterns of Off-Label Use of Rituximab for SLE

Nature Reviews Rheumatology
Rheumatology
2016English

Outcome of Radiological Interventions in Pediatric Gastrointestinal Diseases: A Large Tertiary Center Experience

JGH Open
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy